Risperidone-to-methylphenidate switch reaction in children: Three cases

Journal of Psychopharmacology

Volumn 21, Issue 2, 2007, Pages 216-219

  Sabuncuoglu, Osman ^a,b  

^a MARMARA UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Child; Conduct disorder; Methylphenidate; Risperidone

Indexed keywords

METHYLPHENIDATE; RISPERIDONE;

ADOLESCENT; AGITATION; ANAMNESIS; ARTICLE; ATTENTION DEFICIT DISORDER; CASE REPORT; CLINICAL FEATURE; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPERACTIVITY; IRRITABILITY; MALE; OPPOSITIONAL DEFIANT DISORDER; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIORITY JOURNAL; SIDE EFFECT;

ADOLESCENT; AKATHISIA, DRUG-INDUCED; ANTIPSYCHOTIC AGENTS; ATTENTION DEFICIT AND DISRUPTIVE BEHAVIOR DISORDERS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHILD, PRESCHOOL; CONDUCT DISORDER; DRUG INTERACTIONS; FEMALE; HUMANS; IRRITABLE MOOD; MALE; METHYLPHENIDATE; PSYCHOMOTOR AGITATION; RECEPTORS, SENSORY; RISPERIDONE;

EID: 33847106488     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881107069466     Document Type: Article

References (18)

1. Aman M G, Binder C, Turgay A (2004) Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behaviour disorders, and subaverage IQ. J Child Adolesc Psychopharmacol 14: 243 - 254
2. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn (DSM-IV). American Psychiatric Press, Washington, DC
3. Baron J C, Martinot J L, Cambon H, Boulenger J P, Poirier M F, Caillard V, Blin J, Huret J D, Loc'h C, Maziere B (1989) Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levels. Psychopharmacology (Berl) 99: 463 - 472
4. Benjamin E, Salek S (2005) Stimulant-atypical antipsychotic interaction and acute dystonia. J Am Acad Child Adolesc Psychiatry 44: 510 - 512
5. Blin O (1999) A comparative review of new antipsychotics. Can J Psychiatry 44: 235 - 244
6. Borison R L, Diamond B, Pathiraja A, Meibach R C (1994) Pharmacokinetics of risperidone in chronic schizophrenic patients. Psychopharmacol Bull 30: 193 - 197
7. Cheng-Shannon J, McGough J J, Pataki C, McCracken J T (2004) Second-generation antipsychotic medications in children and adolescents. J Child Adolesc Psychopharmacol 14: 372 - 394
8. Connor D F, Benjamin S, Ozbayrak K R (1995) Case study: neuroleptic withdrawal dyskinesia exacerbated by ongoing stimulant treatment. J Am Acad Child Adolesc Psychiatry 34: 1490 - 1494
9. Ilgin N, Senol S, Gucuyener K, Gokcora N, Sener S (2001) Is increased D2 receptor availability associated with response to stimulant medication in ADHD? Dev Med Child Neurol 43: 755 - 760
10. Moll G H, Hause S, Ruther E, Rothenberger A, Huether G (2001) Early methylphenidate administration to young rats causes a persistent reduction in the density of striatal dopamine transporters. J Child Adolesc Psychopharmacol 11: 15 - 24
11. Patel N C, Crismon M L, Hoagwood K, Jensen P S (2005) Unanswered questions regarding atypical antipsychotic use in aggressive children and adolescents. J Child Adolesc Psychopharmacol 15: 270 - 284
12. Rush C R, Stoops W W, Hays L R, Glaser P E, Hays L S (2003) Risperi-done attenuates the discriminative-stimulus effects of d-amphetamine in humans. J Pharmacol Exp Ther 306: 195 - 204
13. Shea S, Turgay A, Carroll A, Schulz M, Orlik H, Smith I, Dunbar F (2004) Risperidone in the treatment of disruptive behavioural symptoms in children with autistic and other pervasive developmental disorders. Pediatrics 114: e634 - e641
14. Silvestri S, Seeman M V, Negrete J C, Houle S, Shammi C M, Remington G J, Kapur S, Zipursky R B, Wilson A A, Christensen B K, Seeman P (2000) Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study. Psychopharmacology (Berl) 152: 174 - 180
15. Simeon J, Milin R, Walker S (2002) A retrospective chart review of risperidone use in treatment-resistant children and adolescents with psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 26: 267 - 275
16. Tarazi F I, Zhang K, Baldessarini R J (2001) Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: implications for antipsychotic drug treatment. J Pharmacol Exp Ther 297: 711 - 717
17. Turgay A, Binder C, Snyder R, Fisman S (2002) Long-term safety and efficacy of risperidone for the treatment of disruptive behaviour disorders in children with subaverage IQs. Pediatrics 110: e34 - e34
18. Vles J S, Feron F J, Hendriksen J G, Jolles J, van Kroonenburgh M J, Weber W E (2003) Methylphenidate down-regulates the dopamine receptor and transporter system in children with attention deficit hyper-kinetic disorder (ADHD). Neuropediatrics 34: 77 - 80